Looking to expand your partner network with leading companies like Pierre Fabre? Consider joining Inpart's global network for free.
News and Trends 22 Jan 2018
New Triple Combination Therapy Boosts Colorectal Cancer Survival
Pierre Fabre and Array BioPharma’s combination therapy for colorectal cancer has improved progression-free survival in a Phase III trial. French pharma Pierre Fabre and American biopharma Array BioPharma, has carried out an initial safety lead-in study for a Phase 3 trial evaluating a triple combination therapy for the treatment of metastatic colorectal cancer patients. The therapy was […]